| Asset | Level | Change |
|---|---|---|
| MERVAL | 2,579,970.00 | -0.66% |
| USD/ARS | 1,400.50 | -1.02% |
| YPF | 35.20 | +1.53% |
| MercadoLibre | 1,769.03 | +3.21% |
| Globant | 52.00 | +4.33% |
| Soybeans | 1,173.50 | +1.65% |
| Gold | 5,173.10 | +1.03% |
| Bitcoin | 72,639.20 | -0.10% |
| Data | Prior | Cons | Actual |
|---|---|---|---|
| No events available | |||
| Data | Prior | Cons | Time |
|---|---|---|---|
| No events available | |||
Argentine markets saw modest pullbacks on March 4, 2026, with the Merval index dropping 0.66% to close at 2,579,970, weathering an intraday drop of up to 3% as noted in local reports. The USD/ARS official exchange rate decreased 1.02% to 1,400.50, reflecting peso strengthening likely aided by BCRA reserve efforts. YPF shares increased 1.53% to 35.20, driven by Vaca Muerta progress and firming global oil prices.MercadoLibre climbed 3.21% to 1,769.03, supported by e-commerce strength, while Globant advanced 4.33% to 52.00 amid tech sector gains. Soybean prices rose 1.65% to 1,173.50, enhancing agricultural export revenues on solid international demand. Gold advanced 1.03% to 5,173.10, offering reserve hedging benefits.Bitcoin edged down 0.10% to 72,639.20, maintaining relative stability. Country risk fell to 598 basis points, indicating better investor confidence in sovereign debt. No significant data releases occurred, directing attention to market flows and exchange rate dynamics.
March 5, 2026, presents a light economic calendar with no planned Argentine data releases or events. Markets may focus on peso crawling peg movements and any impromptu BCRA updates on reserves. Energy sector developments, such as Vaca Muerta output, could affect stocks like YPF.Sentiment might hinge on global commodity shifts in soybeans and gold. Expect subdued trading absent external disruptions. Informal talks on IMF program adherence could influence bond pricing.
Fiscal adjustments in Argentina are advancing IMF program goals, with subsidy cuts helping deficit reduction despite domestic resistance. Vaca Muerta shale production is expanding, eyeing LNG export potential to diversify from agriculture. Inflation is moderating, with trends pointing to single-digit yearly figures by mid-2026.Parallel exchange rates are converging with the official, suggesting effective capital controls.
Commodity gains supported Argentina's export profile, with soybeans up 1.65% on Asian demand, aiding trade balances. Gold rose 1.03% to 5,173.10 via safe-haven flows, bolstering reserve strategies amid FX fluctuations. The Iran crisis, per reports, risks LNG supply disruptions, possibly lifting global energy prices and favoring Argentina's Vaca Muerta initiatives.Bitcoin dipped 0.10% to 72,639.20, showing crypto steadiness that may impact informal capital movements. AI in healthcare is forecast to hit USD 1,222.12 billion by 2035 at 41.5% CAGR, driven by imaging and diagnostics, potentially drawing investment to Argentina's tech firms like Globant. The proteomics market is projected to exceed USD 148.72 billion by 2035, fueled by drug discovery and precision medicine, creating biotech export avenues.India's fuel shortage from Persian Gulf issues could heighten demand for alternatives, benefiting Argentina's energy output. These factors provide a constructive global setting for Argentina's commodity-reliant economy.
The BCRA upheld its crawling peg with a 2% monthly devaluation rate, aiding the USD/ARS decline of 1.02% as reserve accumulation progresses under IMF directives. Recent updates stress reserve targets without new rate moves, consistent with easing inflation. FX interventions seem to stabilize the parallel blue dollar, reducing the official-parallel gap and arbitrage.Capital controls stay firm to curb outflows, aligning with IMF fiscal demands. Official remarks reaffirm readiness for monetary tightening if inflation rises, shaping expectations for future rate adjustments. These measures promote peso stability, aiding Merval trends and bond performance.Markets view this as commitment to IMF conditions for disbursements.